4-(4,4,5,5-Tetramethyl-1,3,2- dioxaborolan-2-yl)-1H-pyrazole, 98.0%, 500g

2,2'-((2-((2-Hydroxyethyl)amino)ethyl)azanediyl)bis(ethan-1-ol), 97%, 250mg

(S)-4-N-Trityl-2-methyl-piperazine, 98.0%, 1g

(2S,4S)-4-Hydroxypyrrolidine-2-carboxylic acid, 98.0%, 10g

4,5-Dimethoxy-2-methylaniline, 95.0%, 10g

2-(Methyl-2-pyridinylamino)ethanol, 97.0%, 10g

(5-Aminopyrazin-2-yl)dimethylphosphine oxide, 98%, 250mg

(S)-3-((S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one, 95.0%, 10g

4-Amino-N-methyl-benzenesulfonamide, 95.0%, 5g

Ethyl 6-aminohexanoate hydrochloride, 95.0%, 100g

5-Chloro-2,3-difluoropyridine>93.0%(GC)5g

6-METHOXY-2-METHYL-1H-INDOLE, 95.0%, 250mg

anti-Keratin K18 mouse monoclonal, Ks18.04, 1 ml